SYMPHONY-PE Study for Treatment of Pulmonary Embolism

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT06062329

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Imperative Care, Inc. (from the registry)
Registry
  • NCT NCT06062329
Other papers using this trial's data
  • Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE Circulation. Cardiovascular interventions, 2026-09 DOI, PubMed 42312382, PMC13574359 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06062329. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-13 (actual); primary completion 2025-05-04 (actual). Results posted on 2026-08-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
Condition
Acute Pulmonary Embolism
Condition
Thromboembolism
Condition
Emboli, Pulmonary
Condition
Thrombosis
Condition
Thrombus; Embolism
Condition
Embolism
Condition
Cardiovascular Diseases
Condition
Vascular Diseases
Intervention (Device)
Symphony Thrombectomy System
Lead sponsor
Imperative Care, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06062329
Content hash
6500694cfd8d6819260de76bcd0a7cfaeddb16641cc632af95164fcc908031e3